“Combination Phenylbutyrate Gemcitabine Therapy Effectively Inhibits in Vitro and in Vivo Growth of NSCLC by Intrinsic Apoptotic Pathways”. Journal of Carcinogenesis 5, no. 1 (February 28, 2006). Accessed December 7, 2025. https://carcinogenesis.com/index.php/JOC/article/view/227.